Anjuman Begum

Dr. Anjuman Begum is a Research Fellow at the School of Pharmacy and Pharmaceutical Sciences, The University of Queensland. Her academic career focuses on drug/gene delivery, peptide chemistry, and nanotechnology for therapeutic applications.

• PhD, The University of Queensland (2018)
• Adjunct Fellow, School of Pharmacy and Pharmaceutical Sciences
• Researcher in targeted oligonucleotide delivery systems

Her research explores:

• Design of peptide-based nanocarriers for CRISPR/Cas9 gene editing
• siRNA/pDNA delivery systems using GRPR-targeted hybrids
• Formulation development for sustained-release pharmaceuticals
• Pharmacological evaluation of ethnobotanical extracts

Key trends in her 15 most recent publications (2013-2023) include:

• Targeted delivery via peptide-nanoparticle conjugates
• Advances in nonviral gene editing platforms
• Method validations for respiratory and diabetes medications
• Phytochemical investigations across Bangladesh's traditional medicine

As a supervisor, Dr. Begum currently oversees:

• Development of peptide-based gene delivery platforms (PhD candidate)
• Previously guided optimization of gene delivery systems for in vivo applications (completed PhD)

She collaborates with:

• Emeritus Professor Istvan Toth
• Associate Professor Peter Moyle
• Teams at UQ's Drug Delivery and Nanomedicine Group
• Contributor to the Safe and Effective Medication Collaborative